cdn mobile

Drug test on Lapu-Lapu City Hall employees yields two positive results

By: Futch Anthony Inso - CDN Digital | June 09,2022 - 10:09 AM

Lapu-Lapu employees

CDN Digital photo | Futch Anthony Inso

LAPU-LAPU CITY, Cebu—Two casual employees from Lapu-Lapu City Hall have tested positive for illegal drugs.

This was confirmed by Garry Lao, head of the City of Lapu-Lapu Office for Substance Abuse Prevention (CLOSAP).

The result, however, would still need to undergo confirmatory test.

Lao said that while waiting for the result of the confirmatory test, they will also be subjected to monitoring by CLOSAP.

He added that on Wednesday, CLOSAP was able to test 277 city hall employees, including employees from the Clean and Green and City Hall Marshalls.

Meanwhile, Lao said that they also called the attention of the 192 employees who failed to submit themselves in the drug test on June 1, 2022.

“Actually karon kadtong mga wala maka-drug test, ato man gipapaari,” Lao said.

The said employees will submit their letter of explanation today, June 9, 2022, after the City Administrator’s Office issued a memorandum against them. 

/bmjo

READ MORE:

CLOSAP conducts another round of drug testing

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Read Next

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

TAGS: CLOSAP, drug test
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.